COMPARISON OF MCN-3495 [N-(1-METHYL-2-PYRROLIDINYLIDENE)-N'-PHENYL-1-PYRROLIDINECARBOXIMIDAMIDE], A NEW, ORALLY EFFECTIVE, HYPOGLYCEMIC AGENT, WITH BIGUANIDES

被引：12

作者：

TUTWILER, GF

BRIDI, G

机构：

来源：

DIABETES | 1978年 / 27卷 / 08期

关键词：

D O I：

10.2337/diab.27.8.868

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：868 / 876

页数：9

共 24 条

[1] ORAL VERSUS INTRAVENOUS ADMINISTRATION OF BUTYLBIGUANIDE - EFFECT ON ORAL GLUCOSE-TOLERANCE IN NORMAL HUMANS [J].

BERGER, EG ;

MOEHR, P .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1976, 6 (03) :221-228

[2]

BIGELOWSHERMAN JD, 1969, ACTA DIABETOL LAT, V6, P507

[3]

BLICKENS DA, 1971, J PHARMACOL EXP THER, V177, P536

[4]

BLICKENS PA, 1969, TOXICOL APPL PHARMAC, V14, P393

[5] INSULIN AND ORAL HYPOGLYCEMIC AGENTS .1. PHYSIOLOGICAL AND CLINICAL PHARMACOLOGICAL ASPECTS [J].

BREIDAHL, HD ;

STAWELL, JR ;

TAFT, P ;

ENNIS, GC ;

MARTIN, FIR .

DRUGS, 1972, 3 (1-2) :79-&

[6] ANALYSIS OF INHIBITORY EFFECT OF BIGUANIDES ON GLUCOSE ABSORPTION - INHIBITION OF ACTIVE SUGAR TRANSPORT [J].

CASPARY, WF ;

CREUTZFE.W .

DIABETOLOGIA, 1971, 7 (05) :379-&

[7]

CREUTZFELDT W, 1971, REPORTS ORAL DIABETE, P95

[8] EFFECT OF BIGUANIDES ON INTESTINAL ABSORPTION OF GLUCOSE [J].

CZYZYK, A ;

TAWECKI, J ;

SADOWSKI, J ;

PONIKOWSKA, I ;

SZCZEPANIK, Z .

DIABETES, 1968, 17 (08) :492-+

[9]

Harsant P R, 1969, Postgrad Med J, V45, P20

[10]

HERMANN LS, 1973, DAN MED BULL, V20, P65

← 1 2 3 →